Connect with us


Cannabis Giant Canopy Growth Makes a $2 Billion Net Loss




Canopy Growth, formerly Tweed Marijuana Inc. has reported a net loss of $2 billion for the quarter that ended on 30th June. This loss was mostly as a result of a write down, but the company admits that cannabis sales were also low during the period.  This announcement that was made last Friday had a spiraling effect on the stock market; causing the company’s share prices to drop. The Canada-based company that produces medical cannabis has struggled to become profitable and this core loss will further dim investor hopes of achieving profitability in the near future.
Canopy Growth made a non-cash write-off of $1.72 billion which made up a huge chunk of the $2.1 billion loss. The company also made losses in the recreational market as sales plunged by 38%. The executives have attributed this to increased competition as more businesses have entered the market as well as price compression.
However, executives from the company have maintained that the company is on the path toward profitability. The CEO of Canopy, David Klein, had this to say:
” I don’t want anyone thinking that we’re not spending almost all our waking hours on stopping the cash burn in Canada.”
The chief financial officer, Judy Hong, has echoed similar sentiments. She went further to give reasons why the company was yet to achieve profitability. The market in Canada had apparently developed in a different way from how the company had envisioned it developing. Regulatory red tape and a strong illicit market have also served as significant setbacks.
Canopy is currently reviewing its strategy and will be soon focusing on the premium market that offers better prices and a loyal customer base in the long run. The company has been laying off staff hopes to make a saving of about $150 million within the next one and a half years.

Lydia K. (Bsc. RN) is a cannabis writer, which, considering where you’re reading this, makes perfect sense. Currently, she is a regular writer for Mace Media. In the past, she has written for MyBud, RX Leaf & Dine Magazine (Canada), CBDShopy (UK) and Cannavalate & Pharmadiol (Australia). She is best known for writing epic news articles and medical pieces. Occasionally, she deviates from news and science and creates humorous articles. And boy doesn't she love that! She equally enjoys ice cream, as should all right-thinking people.

Posts/Pages Sidebar Form

Advertiser Disclosure: is committed to rigorous editorial standards to provide our readers with accurate reviews and ratings. We may receive compensation when you click on links to products we reviewed.

Educational & Medical Disclaimer: This information is for educational purposes only. We are not medical professionals, and no information on this website should be construed as medical advice. For more information please view our Educational & Medical Disclaimer.

Minimum Age: To use this website you must be the minimum age as allowed in your jurisdiction. USA visitors must be 21, visitors from Canada must be 18 or 19 years of age depending on the province. It is illegal for a person younger than this to use this website.